Nutrients,
Journal Year:
2024,
Volume and Issue:
16(24), P. 4303 - 4303
Published: Dec. 13, 2024
Background:
Coffee
and
tea
are
widely
consumed
beverages,
but
their
long-term
effects
on
cognitive
function
aging
remain
largely
unexplored.
Lifestyle
interventions,
particularly
dietary
habits,
offer
promising
strategies
for
enhancing
performance
preventing
decline.
Methods:
This
study
utilized
data
from
the
UK
Biobank
cohort
(n
=
12,025)
to
examine
associations
between
filtered
coffee,
green
tea,
standard
consumption
neural
network
functional
connectivity
across
seven
resting-state
networks.
We
focused
networks
spanning
prefrontal
occipital
areas
that
linked
complex
behavioral
functions.
Linear
mixed
models
were
used
assess
main
of
coffee
consumption,
as
well
interactions
with
Apolipoprotein
E
(APOE)
genetic
risk—the
strongest
risk
factor
Alzheimer’s
disease
(AD).
Results:
Higher
was
associated
increased
in
several
networks,
including
Motor
Execution,
Sensorimotor,
Fronto-Cingular,
a
Prefrontal
+
‘What’
Pathway
Network.
Similarly,
greater
intake
enhanced
Extrastriate
Visual
Primary
Networks.
In
contrast,
higher
reduced
such
Memory
Consolidation,
“What”
The
APOE4
genotype
family
history
AD
influenced
relationship
Consolidation
Additionally,
modified
association
Sensorimotor
Conclusions:
distinct
patterns
brain
activity
may
provide
insights
into
AD-related
changes.
genotype,
particular,
appears
play
significant
role
modulating
these
relationships.
These
findings
enhance
our
knowledge
how
commonly
beverages
influence
potentially
among
older
adults.
Molecular and Cellular Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 20, 2025
Abstract
Neurodegenerative
diseases
(NDs)
are
caused
by
progressive
neuronal
death
and
cognitive
decline.
Epigallocatechin
3-gallate
(EGCG)
is
a
polyphenolic
molecule
in
green
tea
as
neuroprotective
agent.
This
review
evaluates
the
therapeutic
effects
of
EGCG
explores
molecular
mechanisms
that
show
its
properties.
protects
neurons
several
ways,
such
lowering
oxidative
stress,
stopping
Aβ
from
aggregation
together,
changing
cell
signaling
pathways,
decreasing
inflammation.
Furthermore,
it
promotes
autophagy
improves
mitochondrial
activity,
supporting
survival.
Clinical
studies
have
demonstrated
supplementation
can
reduce
neurodegenerative
biomarkers
enhance
function.
provides
insights
into
potential
treating
various
NDs.
reduces
stress
scavenging
free
radicals
enhancing
antioxidant
enzyme
aiding
defense.
It
also
abilities
inhibiting
toxicity
peptides.
changes
important
pathways
like
Nrf2,
PI3K/Akt,
MAPK,
which
necessary
for
survival,
death,
Additionally,
has
strong
anti-inflammatory
properties
because
inhibits
microglial
activation
downregulates
pro-inflammatory
cytokines.
function
reducing
increasing
ATP
synthesis,
promoting
biogenesis,
neurons’
survival
energy
metabolism.
In
addition,
triggers
autophagy,
cellular
process
breaks
down
recycles
damaged
proteins
organelles,
eliminating
neurotoxic
aggregates
maintaining
homeostasis.
Moreover,
holds
significant
promise
an
ND
treatment,
but
future
research
should
focus
on
bioavailability
understanding
long-term
clinical
effects.
Future
improving
delivery
settings.
potentially
be
agent
managing
NDs,
indicating
need
further
research.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(7), P. 762 - 762
Published: June 24, 2024
Neurodegenerative
diseases
are
a
significant
challenge
to
global
healthcare,
and
oxidative
stress
plays
crucial
role
in
their
development.
This
paper
presents
comprehensive
analysis
of
the
neuroprotective
potential
olive
oil,
with
primary
focus
on
its
antioxidant
properties.
The
chemical
composition
including
key
antioxidants,
such
as
oleuropein,
hydroxytyrosol,
oleocanthal,
is
systematically
examined.
mechanisms
by
which
these
compounds
provide
neuroprotection,
counteracting
damage
modulating
pathways,
explored.
efficacy
oil
evaluated
synthesizing
findings
from
various
sources,
vitro
studies,
animal
models,
clinical
trials.
integration
into
dietary
patterns,
particularly
Mediterranean
diet,
broader
implications
neurodegenerative
disease
prevention
also
discussed.
challenges
translating
preclinical
applications
acknowledged
future
research
directions
proposed
better
understand
mitigating
risk
conditions.
review
highlights
not
only
component,
but
promising
candidate
preventive
neurology,
advocating
for
further
investigation
context
diseases.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(7), P. 862 - 862
Published: July 18, 2024
Alzheimer’s
disease
(AD)
is
a
progressive
neurodegenerative
disorder
that
comprises
amyloid-beta
protein
(Aβ)
as
main
component
of
neuritic
plaques.
Its
deposition
considered
trigger
for
AD
pathogenesis,
progression,
and
the
clinical
symptoms
cognitive
impairment.
Some
distinct
pathological
features
include
phosphorylation
tau
protein,
oxidative
stress,
mitochondrial
dysfunction.
These
consequences
tend
to
produce
reactive
oxygen
species
(ROS),
resulting
in
dysregulation
various
signaling
pathways
neuroinflammation
neurodegeneration.
The
relationship
between
Aβ
cascade
stress
pathogenesis
like
“chicken
egg”
story,
with
etiology
regarding
these
two
factors
remaining
question
“which
comes
first.”
However,
this
review,
we
have
tried
our
best
clarify
interconnection
mechanisms
show
precise
cause-and-effect
relationship.
Based
on
above
hallmarks
AD,
several
therapeutic
strategies
using
natural
antioxidants,
monoclonal
antibodies,
vaccines
are
employed
anti-Aβ
therapy
decrease
ROS,
burden,
chronic
neuroinflammation,
synaptic
failure.
antioxidants
immunotherapeutics
demonstrated
significant
neuroprotective
effects
symptomatic
relief
vitro
vivo
models,
well
trials
AD.
none
them
received
final
approval
enter
drug
market
mitigating
In
extensively
elaborate
pitfalls,
assurances,
important
crosstalk
concerning
current
therapy.
Additionally,
discuss
future
development
more
Aβ-targeted
approaches
optimization
treatment
mitigation.
Food & Function,
Journal Year:
2024,
Volume and Issue:
15(16), P. 8330 - 8344
Published: Jan. 1, 2024
:
Limited
and
conflicting
evidence
exists
for
the
associations
between
tea,
coffee,
caffeine
intake
risk
of
dementia
Alzheimer's
disease
(AD).
This
meta-analysis
aimed
to
elucidate
these
quantify
potential
dose-response
relationships.
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 4299 - 4317
Published: May 1, 2024
Background:
Inhibition
of
amyloid
β
protein
fragment
(Aβ)
aggregation
is
considered
to
be
one
the
most
effective
strategies
for
treatment
Alzheimer's
disease.
(-)-Epigallocatechin-3-gallate
(EGCG)
has
been
found
in
this
regard;
however,
owing
its
low
bioavailability,
nanodelivery
recommended
practical
applications.
Compared
chemical
reduction
methods,
biosynthesis
avoids
possible
biotoxicity
and
cumbersome
preparation
processes.
Materials
Methods:
The
interaction
between
EGCG
Aβ
42
was
simulated
by
molecular
docking,
green
tea-conjugated
gold
nanoparticles
(GT-Au
NPs)
EGCG-Au
NPs
were
synthesized
using
EGCG-enriched
tea
solutions,
respectively.
Surface
active
molecules
particles
identified
analyzed
various
liquid
chromatography-tandem
triple
quadrupole
mass
spectrometry
methods.
ThT
fluorescence
assay,
circular
dichroism,
TEM
used
investigate
effect
on
inhibition
aggregation.
Results:
as
well
apigenin,
quercetin,
baicalin,
glutathione
capping
ligands
stabilized
surface
GT-Au
NPs.
They
more
or
less
inhibited
promoted
fibril
disaggregation,
with
being
effective,
which
bound
through
hydrogen
bonding,
hydrophobic
interactions,
etc.
resulting
39.86%
88.50%
disaggregation
effects,
not
free
EGCG,
whereas
multiple
thiols
polyphenols
accelerated
optimized
heavy
metal
detoxification.
conferred
efficacy
diverse
particles,
effects
54.69%
88.75%,
respectively,
while
increasing
yield,
enhancing
water
solubility,
decreasing
cost.
Conclusion:
Biosynthesis
a
promising
simple
economical
drug-carrying
approach
confer
pharmacophore
Au
This
could
design
new
drug
candidates
treat
Keywords:
nanoparticles,
synthesis,
(-)-epigallocatechin-3-gallate,
chromatography
tandem
spectrometry,
protein,
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 11, 2024
With
the
passage
of
time,
people
step
toward
old
age
and
become
more
prone
to
several
diseases
associated
with
age.
One
such
is
Alzheimer's
disease
(AD)
which
results
into
neuronal
damage
dementia
progression
The
existing
therapeutics
has
been
hindered
by
various
enkindles
like
less
eminent
between
remote
populations,
affordability
issues
toxicity
profiles.
Moreover,
lack
suitable
therapeutic
option
further
worsens
quality
life
in
older
population.
Developing
an
efficient
intervention
cure
AD
still
a
challenge
for
medical
fraternity.
Recently,
alternative
approaches
attain
attention
researchers
focus
on
plant-based
therapy
mitigating
AD.
In
this
context,
flavonoids
gained
centrality
as
feasible
treatment
modifying
neurological
deficits.
This
review
mainly
focuses
pathological
facets
economic
burden
Furthermore,
we
have
explored
possible
mechanism
preclinical
clinical
aspects
curing
Flavonoids
being
potential
therapeutic,
target
pathogenic
factors
oxidative
stress,
inflammation,
metal
toxicity,
Aβ
accumulation,
modulate
neurotransmission
insulin
signaling.
review,
emphasized
neuroprotective
effects
pathology,
both
experimental
findings.
While
studies
suggest
promising
benefits,
data
remains
limited
inconclusive.
Thus,
high-quality
trials
are
necessary
validate
efficacy
study
aim
promote
therapies
encourage
add
regular
diet
avail
beneficial
preventive
BMC Complementary Medicine and Therapies,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: April 5, 2024
Abstract
Background
Pneumonia,
the
acute
inflammation
of
lung
tissue,
is
multi-factorial
in
etiology.
Hence,
continuous
studies
are
conducted
to
determine
mechanisms
involved
progression
disease
and
subsequently
suggest
effective
treatment.
The
present
study
attempted
evaluate
effects
Epigallocatechin-3-Gallate
(EGCG),
an
herbal
antioxidant,
on
inflammation,
oxidative
stress,
apoptosis,
autophagy
a
rat
pneumonia
model.
Methods
Forty
male
Wistar
rats,
5
months
old
250–290
g
were
divided
into
four
groups
including
control,
EGCG,
experimental
(i/p
LPS
injection,
1
mg/kg),
treated
with
EGCG
(i/p,
15
mg/kg,
h
before
3
after
instillation).
Total
cell
number
bronchoalveolar
lavage
fluid,
(TNF-a,
Il-6,
IL-1β,
NO),
stress
(Nrf2,
HO-1,
SOD,
CAT,
GSH,
GPX,
MDA,
TAC),
apoptosis
(BCL-2,
BAX,
CASP-3
CASP-9),
(mTOR,
LC3,
BECN1)
evaluated.
Results
findings
demonstrated
that
suppresses
LPS-induced
activation
inflammatory
pathways
by
significant
reduction
markers
(
p
-value
<
0.001).
In
addition,
upregulation
BCL-2
downregulation
BAX
caspases
revealed
suppressed
apoptosis.
Furthermore,
ECGC
injury
while
promoting
rats
0.05).
Conclusion
current
could
suppress
promote
models
suggesting
promising
therapeutical
properties
this
compound
be
used
management.